Comorbidities included type 2 diabetes mellitus (n = 6), overweight (n = 10), cancer (n = 1), and hypertension (n = 16), with four patients being on renin‐angiotensin system (RAS) blockade therapy. This evidence concerns the gene REN and type 2 diabetes mellitus.